Thesis Submitted by. Moataz Hamed Mohamed. M.B.B.Ch, M.Sc. (Ophthalmology) In Partial Fulfillment of MD Degree in Ophthalmology Under Supervision of
|
|
- Ethel Waters
- 5 years ago
- Views:
Transcription
1 Prospective randomized study comparing micropulse diode laser photocoagulation and argon green laser photocoagulation for treatment of clinically significant diabetic macular oedema Thesis Submitted by Moataz Hamed Mohamed M.B.B.Ch, M.Sc. (Ophthalmology) In Partial Fulfillment of MD Degree in Ophthalmology Under Supervision of Prof. Dr. Mostafa Mostafa Bahgat Professor of Ophthalmology Faculty of Medicine Cairo University Prof. Dr. Nihal Adel Hassan Professor of Ophthalmology Faculty of Medicine Cairo University Prof. Dr. Ihab Saad Othman Professor of Ophthalmology Faculty of Medicine Cairo University Cairo University Faculty of Medicine 2012
2 Acknowledgement Acknowledgement I would like to express my gratitude to Kasr Al-Ainy, our great school, for every piece of information I have learned. I would like to express my deep gratitude and appreciation to Prof. Dr. Mostafa Mostafa Bahgat, Professor of Ophthalmology- Cairo University, for his valuable advices, continuous support, scientific additions and sincere help throughout the work. My profound thanks, respect and deep gratitude to Prof. Dr. Nihal Adel Hassan, Professor of Ophthalmology- Cairo University, for her fruitful advices and help throughout the work. My deepest gratitude and appreciation to Prof. Dr. Ihab Saad Othman, Professor of Ophthalmology- Cairo University for his fruitful assistance and valuable suggestions throughout the work. Special thanks to all my Professors and colleagues in the Ophthalmology department, Faculty of medicine, Cairo University for their encouragement and help. My deepest thanks to my family to them I owe everything. Moataz Hamed
3 Abstract The purpose of this study is to assess effect of micropulse diode laser (MPDL) on best corrected visual acuity (BCVA), central foveal thickness(cft), contrast sensitivity measured at 5 spatial frequencies and on macular scar formation during treatment of clinically significant diabetic macular oedema (CSME) as compared to conventional argon green laser (CGL) treatment. This is a single-center, prospective, interventional, comparative study. Twenty four patients (40 eyes) with diabetic CSME were randomly assigned to MPDL (n=20) or CGL (n=40) photocoagulation. Micropulse diode laser photocoagulation is superior to CGL treatment for CSME regarding contrast sensitivity improvement and macular scar formation. Micropulse diode laser photocoagulation is equally effective as CGL treatment for CSME regarding BCVA and central foveal thickness. Key Words: Micropulse, Argon, laser, diabetic macular oedema, contrast sensitivity, macular scar, visual acuity, foveal thickness.
4 Table of contents Table of contents Subject Page - List of figures ii - List of tables vii - List of abbreviations viii - Introduction 1 - Aim of the work 2 - Review: Anatomy of the macula Definition, Epidemiology, Natural history and classification Pathogenesis of diabetic macular oedema Histopathology Diagnosis of diabetic macular oedema Treatment of DME Micropulse diode 42 - Patients and methods 56 - Results 63 - Discussion 84 - Conclusion 95 - Summary 96 - References 99 - Arabic Summary i
5 List of figures List of figures No 1 The anatomical fovea and foveola are contained within the center of the anatomical macula. 2 Section in the region of the foveola. the inner cellular layers are absent and there is an increased density of pigment in the RPE. 3 Focal DME. 4 Diffuse DME. 5 Ischemic maculopathy. 6 Diabetic retinal pigment epitheliopathy. 7 Optical coherence tomography showing focal macular oedema. 8 Schematic presentation of the inner and outer BRBs and their relative location. 9 Schematic diagram illustrating the course of AGE formation on a hypothetical fibrilar protein. 10 Schematic of tight junction proteins. 11 Schematic diagram showing the site of action of different anti- VEGF. 12 Effects of posterior vitreous detachment on diabetic retinopathy. 13 Posterior precortical vitreous pocket. 14 Histopathology of exudates. 15 Correlation between OCT, fluorescein angiography and fundus biomicroscopy. 16 OCT shows A) sponge-like retinal swelling B) Newly developed cystoid macular edema. C) Established cystoid macular edema. D) SRD. 17 OCT demonstrating diffuse retinal thickening. 18 OCT of a patient with diabetic cystoid macular edema. ii
6 List of figures 19 OCT demonstrating posterior hyaloidal traction. 20 OCT of a serous retinal detachment. 21 OCT of a patient with posterior hyaloidal traction and traction retinal detachment. 22 Examples of laser treatment techniques (focal and grid). 23 ETDRS-modified protocol versus standard ETDRS photocoagulation: difference in laser burns. 24 Mild macular grid. 25 Schematic diagram showing steroids role in reducing DME. 26 CW Mode (100% Duty Cycle). 27 MicroPulse Mode (10% Duty Cycle). 28 Topcon TRC 50IX retinal camera 29 SD OCT RTvue 30 (A) OcuLight SLx diode laser with micropulse mode. (B) OPTO Advant Green Laser 31 Mean best corrected visual acuity (BCVA) at baseline,3 and 6 months. 32 Mean central macular thickness at baseline, 3 and 6 months. 33 Color fundus photo and FFA show diffuse macular oedema. OCT shows diffuse retinal thickening (CMT= 318µm) months after argon grid, there is decreased oedema (CMT=299µm). Laser marks are seen in FFA. 35 Color fundus photo and FFA show diffuse macular oedema. OCT shows diffuse retinal thickening (CMT= 351µm) months after argon grid, there is decreased oedema and hard exudates (CMT=335µm). Laser marks are seen in FFA. 37 Color fundus photo and FFA show focal macular oedema. OCT shows CMT=252µ months after focal argon treatment, there is decreased oedema (CMT=240µm). Laser scars are seen in color fundus photo. iii
7 List of figures 39 Color fundus photo and FFA show diffuse macular oedema, hard exudates, dot and blot haemorrhages. OCT shows cystoid macular oedema. (CMT= 486µm) months after MPDL grid, there is decreased oedema (CMT=451µm). No laser marks are seen in color photo or FFA. 41 Color fundus photo and FFA show focal macular oedema. OCT shows CMT=283µm months after focal MPDL treatment, there is decreased oedema (CMT=278µm). No laser marks are seen in FFA. 43 Upper OCT shows diffuse macular oedema (CMT=394µm). Middle OCTshows 3 months after MPDL grid (CMT=367µm). Lower OCT shows 6 months after MPDL (CMT=329µm). 44 Upper OCT shows focal macular oedema (CMT=309µm). Lower OCT 6 months done after focal MPDL (CMT=282µm). 45 Upper OCT shows diffuse macular oedema (CMT=394µm). Lower OCT is 6 months after MPDL grid (CMT=368µm). 46 Mean contrast sensitivity of CGL group and MPDL group at baseline showing no statistical significant difference between both groups. 47 Mean contrast sensitivity of CGL group and MPDL group at 3 months showing no statistical significant difference between both groups. 48 Mean contrast sensitivity of CGL group and MPDL group at 6 months showing no statistical significant difference between both groups. 49 Mean contrast sensitivity of CGL group at baseline, 3 and 6months showing no statistical significant improvement between baseline and following visits at different spatial frequencies. 50 Mean contrast sensitivity of MPDL group at baseline, 3 and 6 months showing statistical significant improvement in contrast sensitivity at spatial frequencies 6 and 12 and no statistical significant difference at the other spatial frequencies months after argon laser grid (Upper) fundus photo showing laser scars. (Lower) FFA showing laser marks. iv
8 List of figures 52 Upper OCT showing SRD with CMT=318 µm. Lower OCT (6 months after MPDL grid) shows no SRD with CMT=282 µm. 53 Upper OCT showing SRD with CMT=354µm. Lower OCT (6 months after CGL grid) shows no SRD with CMT=290 µm. 54 A)Fundus photo and FFA shows CSME with hard exudates. B) Fundus photo and FFA shows reduction of CSME and hard exudates. Laser marks are seen at FFA. 55 A) Color fundus photo showing CSME and hard exudates. B) FFA showing cystoid macular oedema. C) OCT showing cystoids macular oedema (CMT= 415µm) months after Argon grid A) Color fundus photo and B) FFA showing persistent macular oedema and laser marks. C) OCT shows persistent cystoids macular oedema (CMT=548µm). This patient had argon supplemental treatment months after supplemental treatment. OCT shows persistent cystoid oedema (CMT=629 µm). Intravitreal TAC is given month after TAC injection. A) Color phundus photo shows decreased macular oedema and laser scars. B) FFA shows laser marks. C) OCT shows reduction of macular oedema. (CMT=303µm) 59 A)Color fundus photo showing CSME and hard exudates. B) FFA showing diffuse macular oedema. C) OCT showing diffuse retinal thickening (CMT= 260µm), hyper-reflective areas with back shadowing denoting hard exudates months after MPDL grid A) Color fundus photo shows increased hard exudates which correlated with elevated serum cholesterol and triglycerids. B) FFA showing persistent macular oedema. No laser marks seen at FFA. C) OCT shows SRD with CMT=375µm. This patient had MPDL supplemental treatment months after supplemental treatment. OCT shows persistent SRD with CMT=395 µm. Intravitreal TAC is given. v
9 List of figures 62 1 month after TAC injection, there is improvement of macular thickening (CMT=253µm) however FFA shows persistent leakage, so this patient needs further laser photocoagulation. Persistent hard exudates need tight serum cholesterol control. vi
10 List of tables List of tables No 1 Diabetic Macular Edema Disease Severity Scale. 2 Correlation between visible-threshold, histological threshold and subthreshold treatment power. 3 Baseline clinical characteristics of the two groups. 4 Central macular thickness in CGL and MPDL groups. 5 Mean contrast sensitivity and SD at baseline and follow up visits. 6 P value for improvement in contrast sensitivity between follow up visits for CGL group showing no statistical significant improvement between baseline and following visits at different spatial frequencies. 7 P value for improvement in contrast sensitivity between follow up visits for MPDL group showing statistical significant improvement in contrast sensitivity at spatial frequencies 6 and 12 and no statistical significant difference at the other spatial frequencies. vii
11 List of Abbreviations List of abbreviations Abbreviation Stands for BRB Blood-retinal barrier DME Diabetic macular oedema RPE Retinal pigment epithelial AGE Advanced glycation end-products GDNF Glial-cell derived neurotropic factor VEGF-A Vascular Endothelial Growth Factor-A ICAM-1 Intercellular adhesion molecule-1 RAGE AGE receptor PEDF Pigment epithelium derived factor ILM Internal limiting membrane ZO Zonula occludens PKC Protein kinase C PVD Posterior vitreous detachment PDR Proliferative diabetic retinopathy OCT BDR Optical coherence tomography Background diabetic retinopathy CSME Clinically significant macular edema viii
12 List of Abbreviations ETDRS DR PDR NPDR Early treatment diabetic retinopathy study Diabetic retinopathy Proliferative diabetic retinopathy Non proliferative diabetic retinopathy FAZ Foveal avascular zone CRT DRCR. Net Central retinal thickness Diabetic retinopathy clinical research network SRD CME Nd:YAG Nd:YLF laser Serous Retinal detachment Cystoid macular edema Neodymium-doped yttrium aluminum garnet Neodymium-doped yttrium lithium fluoride TAC AMD MPD ICG CW MPDL Triamcinolone Age-related macular degeneration Micropulse diode Indocyanine green Continuous wave Micropulse diode laser photocoagulation CGL Green laser photocoagulation FAF Fundus autofluorescence CMT Central macular thickness metdrs Modified early treatment diabetic retinopathy study ix
13 List of Abbreviations ND-SDM HD-SDM DC FFA SD-OCT CFT PRP SD BCVA Cpd Normal-density subthreshold diode micropulse High-density subthreshold diode micropulse Duty cycle Fundus fluorescein angiography Spectral domain Optical coherence tomography Central foveal thickness Panretinal photocoagulation Standard deviation Best corrected visual acuity Cycle per degree x
14 Introduction Introduction While complications of PDR lead more frequently to severe visual loss, the most common cause of visual impairment among diabetic patients is diabetic macular edema (DME). (Joussen et al., 2007 and Coscas et al, 2010) The Early Treatment of Diabetic Retinopathy Study (ETDRS) showed that visible end point focal laser photocoagulation reduces the risk of moderate vision loss in patients with clinically significant diabetic macular oedema (CSME) by 50% at 3-year follow up. (Early Treatment Diabetic Retinopathy Study Research Group, 1985) The conventional green laser (CGL) treatment is applied in a focal or grid pattern and produces a visible burn in the retina. Enlargement of laser scars after treatment has been reported. (Writing Committee for the Diabetic Retinopathy Clinical Research Network, 2007) Laser burns at various levels of intensity are believed necessary for a successful treatment of CSME, but have never been proven to be a prerequisite in the mechanism of action of laser photocoagulation. Conversely, recent understanding of the modification of gene expression mediated by the healing response of the RPE to thermal injury suggests that the useful therapeutic cellular cascade is activated, not by laser-killed RPE cells, but by the still-viable RPE cells surrounding the burned areas that are reached by the heat diffusion at sublethal thermal elevation. New strategies have been developed for laser treatments that minimize the chorioretinal damage while maintaining at least similar treatment efficacy. (Dorin., 2004; Lavinsky et al., 2011) Sub-threshold micropulse diode laser (MPDL) has recently been shown to be effective in the treatment of CSME and seems to have a theoretical advantage, since the laser burns will affect deeper layers with relative sparing of the inner neurosensory retina, thus reducing the scarring and paracentral scotomas post-treatment. (Figueira et al., 2008) 1
15 Introduction Aim of the work This work aims at assessing the effectiveness of micropulse diode laser versus conventional argon green laser for the treatment of clinically significant diabetic macular oedema regarding: Best corrected visual acuity, Central macula thickness measurement by OCT, Contrast sensitivity and Post laser scarring. 2
16 Topography of the retina: Review of literature Anatomy of the macula 3 Review of literature The area centralis The area centralis or central retina is divisible into the fovea and foveola, with a parafoveal and a perifoveal ring around the fovea. This region of the retina, located in the posterior fundus temporal to the optic disc, is demarcated approximately by the upper and lower arcuate and temporal retinal vessels and has an elliptical shape horizontally. With an average diameter of about 5.5 mm, the area centralis corresponds to approximately 15 of the visual field and it is adapted for accurate diurnal vision and colour discrimination. (Tripathi and Tripathi., 1984) The fovea The fovea, which marks the approximate centre of the area centralis, is located at the posterior pole of the globe, 4 mm temporal to the centre of the optic disc and about 0.8 mm below the horizontal meridian. It has a diameter of 1.85 mm (which represents 5 of the visual field) and an average thickness of 0.25 mm. At the centre of the fovea, the layers of the retina are thinner so that a central concave indentation, the foveola, is produced. The downward-sloping border which meets the floor of the foveal pit is known as the clivus. (Tripathi and Tripathi., 1984) The foveola The foveola, which measures 0.35 mm in diameter and 0.13 mm in thickness, represents the area of the highest visual acuity in the retina, even though its span corresponds to only 1 of the visual field. This is due partly to the sole presence of cone photoreceptors and partly to its avascular nature. The foveola usually appears deeper red than does the adjacent retina because of the rich choroidal circulation of the choriocapillaris which shines through it. (Tripathi and Tripathi., 1984) The macula lutea It is an oval zone of yellow colouration within the central retina. The yellow colour can be observed approximately 5 mm in diameter, in the central retina. This finding may explain the apparent confusion in the use of the terms macula, macular area, and macula lutea clinically and
17 Review of literature histologically. The yellow colouration probably arise from the presence of the carotenoid pigment, xanthophyll, in the ganglion and bipolar cells. Within the area centralis two other regions are distinguished outside the fovea: the parafovea (0.5 mm in width) and the perifovea (1.5 mm in width) Figure (1). (Tripathi and Tripathi., 1984) Figure (1) The anatomical fovea and foveola are contained within the center of the anatomical macula. (Skuta and Cantor, 2011) General architecture of the retina As seen in cross-section by light microscopy, the retina is represented by 10 layers sclerad to vitread they are: l. retinal pigment epithelium; 2. photoreceptor layer of rods and cones; 3. external limiting membrane; 4. outer nuclear layer; 5. outer plexiform layer; 6. inner nuclear layer; 7. inner plexiform layer; 8. ganglion cell layer; 9. nerve fibre layer; 10. internal limiting membrane. Figure (2). (Snell R. and Lemp., 1998) At the fovea the only layers that are present are the retinal pigment epithelium, the photoreceptors (cones only), the external limiting membrane, the outer nuclear layer (which contains the nuclei of the cone cells), the inner fibres of the photoreceptors (the so-called 'Henle's fibre' layer), and the internal limiting membrane. The primary neurons in the visual pathway are the photoreceptors, which constitute the layer of rods 4
18 Review of literature and cones, the outer nuclear layer and the outer plexiform layer. The external limiting membrane is a histologically identifiable attachment site between the photoreceptors and the Muller cells. Bipolar, horizontal, amacrine and interplexiform cells constitute the second-order neurons. The ganglion cell layer and the nerve fibre layer form the conductive network internal to the inner plexiform layer and external to the internal limiting membrane. This network of third-order neurons and their respective axonal processes send the information gathered by the photoreceptors for further processing by the visual cortex. The internal limiting membrane makes intimate contact with the vitreous body, which also contributes in part to the architecture of the former. The Müller cells extend between the two limiting membranes and, together with other glial cells, constitute the neuronal connective tissue cells of the retina. (Bron et al., 1997) Figure (2) Section in the region of the foveola. the inner cellular layers are absent and there is an increased density of pigment in the RPE. The incident light falls directly on the photoreceptor outer segments, reducing the potential for distortion of light by overlying t issue elements. GCL = ganglion cell layer; IPL = inner plexiform layer; INL = inner nuclear layer; OPL = outer plexiform layer; ONL = outer nuclear layer; IS = inner segment of photo receptors; OS = outer segment of photoreceptors; RPE = retinal pigment epithelium. (Skuta and Cantor, 2011) 5
19 Review of literature Definition, Epidemiology, Natural history and Classification of DME While complications of PDR lead more frequently to severe visual loss, the most common cause of visual impairment among diabetic patients is diabetic macular edema (DME). (Joussen et al., 2007 and Coscas et al, 2010) Definition of Diabetic Macular Edema Diabetic macular edema is defined as retinal thickening caused by the accumulation of intraretinal fluid and/or hard exudates within 2 disk diameters of the center of the macula, the fovea. (Coscas et al, 2010) Clinically significant macular edema is defined by the Early Treatment Diabetic Retinopathy Study to include any of the following features: (1) Thickening of the retina at or within 500 µm of the center of the macula; (2) Hard exudates at or within 500 µm of the center of the macula, if associated with thickening of the adjacent retina (not residual hard exudates remaining after the disappearance of retinal thickening); (3) Zone or zones of retinal thickening 1 disk area or larger, any part of which is within 1 disk diameter of the center of the macula. The term clinically significant macular edema (CSME) was coined to characterize the severity of the disease and to provide a threshold level to apply laser photocoagulation. (Early Treatment Diabetic Retinopathy Study Research Group, 1985) Epidemiology In the Wisconsin Epidemiologic Study of Diabetic Retinopathy, the incidence of diabetic macular edema is closely associated with the degree of diabetic retinopathy and the duration and type of the disease. (Klein et al., 1984) The 10-year rate of developing DME was 20.1% in patients with type I diabetes, 13.9% in patients with type II diabetes not using insulin, and 25.4% in type II diabetes patients using insulin. The incidence of macular edema over the 10-year period was associated with higher levels of glycosylated hemoglobin and more severe retinopathy in both younger- and older-onset groups, and increased diastolic blood pressure in the older-onset group. (Klein et al., 1995) The 25-year cumulative incidence in persons with type 1 diabetes mellitus is 29% for macular edema and 17% for clinically significant macular edema and the strongest and most consistent associations were 6
20 7 Review of literature with glycemia and to a lesser extent systolic and diastolic blood pressure and nephropathy as manifest by gross proteinuria. (Klein et al., 2009) Natural history The natural history of DME is characterized by a slow progression of retinal thickening until the center of the macula is involved, causing visual acuity deterioration. Spontaneous resolution of DME is rare and usually secondary to improvement in systemic risk factors, such as glycemic control, hypertension, or hypercholesterolemia. If untreated, 24% of eyes with DME and foveal involvement experience moderate visual loss (defined as a doubling of the visual angle (eg, a decrease from 20/20 to 20/40 or from 20/50 to 20/ 100), a drop of 15 or more letters on ETDRS visual acuity charts, or a drop of 3 or more lines of Snellen equivalent) after 3 years. (Early Treatment Diabetic Retinopathy Study Research Group, 1985) Classification of Diabetic Macular Edema There are two subtypes of diabetic macular edema, focal and diffuse forms. Focal macular edema refers to localized areas of retinal thickening, caused by foci of vascular abnormalities, primarily microaneurysms, and less commonly intraretinal microvascular abnormalities. These have an increased tendency for fluid leakage, which is usually accompanied by hard exudates. The hard exudate pattern can be either focal or (often) ring-shaped Figure (3). (Coscas et al, 2010) Diffuse macular edema is caused by a general diffuse leakage from dilated retinal capillaries (and from microaneurysms and arterioles) throughout the posterior pole of the retina. It is characterized by a more widespread thickening of the macula secondary to generalized abnormal permeability of the retinal capillary bed that appears to be diffusely dilated. Diffuse macular edema tends to occur without significant exudation. It can usually be observed in both eyes with the degree of leakage being similar or extensively different Figure (4). (Coscas et al, 2010) Cystoid macular edema, often associated with diffuse macular edema, results from a generalized breakdown of the blood with fluid accumulation in a petaloid pattern, primarily in the outer plexiform and inner nuclear layers. (Coscas et al, 2010) There are also classifications for ischemic and exudative macular edema. In most cases, a hybrid type of these two can be observed. Ischemic maculopathy is defined by the presence of rarefaction and occlusion of the perifoveal capillary network, with doubling of the extension of the FAZ Figure (5). (Coscas et al, 2010)
OCT Assessment of the Vitreoretinal Relationship in CSME
December 2007 Sonia Rani John et al. - IFIS 375 ORIGINAL ARTICLE OCT Assessment of the Vitreoretinal Relationship in CSME Dr. Manoj S. DNB FRCS, Dr. Unnikrishnan Nair MS DO FRCS, Dr. Gargi Sathish MS Introduction
More informationIs OCT-A Needed As An Investigative Tool During The Management Of Diabetic Macular Edema
Is OCT-A Needed As An Investigative Tool During The Management Of Diabetic Macular Edema Ayman M Khattab MD, FRCS Professor of Ophthalmology Cairo University Diabetic Macular Edema (DME) Diabetic macular
More informationClinically Significant Macular Edema (CSME)
Clinically Significant Macular Edema (CSME) 1 Clinically Significant Macular Edema (CSME) Sadrina T. Shaw OMT I Student July 26, 2014 Advisor: Dr. Uwaydat Clinically Significant Macular Edema (CSME) 2
More informationPART 1: GENERAL RETINAL ANATOMY
PART 1: GENERAL RETINAL ANATOMY General Anatomy At Ora Serrata At Optic Nerve Head Fundoscopic View Of Normal Retina What Is So Special About Diabetic Retinopathy? The WHO definition of blindness is
More informationA Review of Subthreshold Micropulse Laser for Treatment of Macular Disorders
Adv Ther (2017) 34:1528 1555 DOI 10.1007/s12325-017-0559-y REVIEW A Review of Subthreshold Micropulse Laser for Treatment of Macular Disorders Paula Scholz. Lebriz Altay. Sascha Fauser Received: March
More informationOptical Coherence Tomography in Diabetic Retinopathy. Mrs Samantha Mann Consultant Ophthalmologist Clinical Lead of SEL-DESP
Optical Coherence Tomography in Diabetic Retinopathy Mrs Samantha Mann Consultant Ophthalmologist Clinical Lead of SEL-DESP Content OCT imaging Retinal layers OCT features in Diabetes Some NON DR features
More informationOCT in Diabetic Macular Edema and its Correlation with Flourescein Angiography
Uvea OCT in Diabetic Macular Edema and its Correlation with Flourescein Angiography Kirti Jaisingh MS Kirti Jaisingh MS, Yashpal Goel* MS, Kshitij Aditya** DO * Guru Nanak Eye Centre, New Delhi ** Baba
More informationDiabetic Retinopathy. Barry Emara MD FRCS(C) Giovanni Caboto Club October 3, 2012
Diabetic Retinopathy Barry Emara MD FRCS(C) Giovanni Caboto Club October 3, 2012 Outline Statistics Anatomy Categories Assessment Management Risk factors What do you need to do? Objectives Summarize the
More informationThe Quick Guide to OCT Mastery 50 Real Cases with Expert Analysis
OPTICAL COHERENCE TOMOGRAPHY The Quick Guide to OCT Mastery 50 Real Cases with Expert Analysis VOL 1 Sanjay Sharma, MD, FRCS, MSc (Epid), MBA Ophthalmologist, Epidemiologist Queen s University, Canada
More informationROLE OF LASER PHOTOCOAGULATION VERSUS INTRAVITREAL TRIAMCINOLONE ACETONIDE IN ANGIOGRAPHIC MACULAR EDEMA IN DIABETES MELLITUS
ORIGINAL ARTICLE ROLE OF LASER PHOTOCOAGULATION VERSUS INTRAVITREAL TRIAMCINOLONE ACETONIDE IN ANGIOGRAPHIC MACULAR EDEMA IN DIABETES MELLITUS Aggarwal Somesh VP 1, Shah Sonali N 2, Bharwada Rekha M 3,
More informationZEISS AngioPlex OCT Angiography. Clinical Case Reports
Clinical Case Reports Proliferative Diabetic Retinopathy (PDR) Case Report 969 PROLIFERATIVE DIABETIC RETINOPATHY 1 1-year-old diabetic female presents for follow-up of proliferative diabetic retinopathy
More informationDiabetic Retinopathy
Diabetic Retinopathy Diabetes can be classified into type 1 diabetes mellitus and type 2 diabetes mellitus, formerly known as insulin-dependent diabetes mellitus, and non-insulin diabetes mellitus, respectively.
More informationDiagnosis and treatment of diabetic retinopathy. Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City
Diagnosis and treatment of diabetic retinopathy Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City Disclosures Consulted for Novo Nordisk 2017,2018. Will be discussing
More informationVISUAL OUTCOME IN DIABETIC MACULAR EDEMA AFTER GRID LASER TREATMENT
The Professional Medical Journal DOI: 10.17957/TPMJ/16.2856 ORIGINAL PROF-2856 VISUAL OUTCOME IN DIABETIC MACULAR EDEMA AFTER GRID LASER TREATMENT 1. MBBS.FCPS Assistant Professor Ophthalmology Independent
More informationStudy of clinical significance of optical coherence tomography in diagnosis & management of diabetic macular edema
Original Research Article Study of clinical significance of optical coherence tomography in diagnosis & management of diabetic macular edema Neha Kantilal Desai 1,*, Somesh Vedprakash Aggarwal 2, Sonali
More informationCase Report Increase in Central Retinal Edema after Subthreshold Diode Micropulse Laser Treatment of Chronic Central Serous Chorioretinopathy
Case Reports in Ophthalmological Medicine Volume 2015, Article ID 813414, 4 pages http://dx.doi.org/10.1155/2015/813414 Case Report Increase in Central Retinal Edema after Subthreshold Diode Micropulse
More informationTHE ROLE OF anti-vegf IN DIABETIC RETINOPATHY AND AGE RELATED MACULAR DEGENERATION
THE ROLE OF anti-vegf IN DIABETIC RETINOPATHY AND AGE RELATED MACULAR DEGENERATION MOESTIDJAB DEPARTMENT OF OPHTHALMOLOGY SCHOOL OF MEDICINE AIRLANGGA UNIVERSITY DR SOETOMO HOSPITAL SURABAYA INTRODUCTION
More informationCOMPARISON OF INTRAVITREAL TRIAMCINOLONE INJECTION VS LASER PHOTOCOAGULATION IN ANGIOGRAPHIC MACULAR EDEMA IN DIABETIC RETINOPATHY
Original Article COMPARISON OF INTRAVITREAL TRIAMCINOLONE INJECTION VS LASER PHOTOCOAGULATION IN ANGIOGRAPHIC MACULAR EDEMA IN DIABETIC RETINOPATHY Aggarwal Somesh V 1, Shah Sonali N 2, Bharwada Rekha
More informationOCT Angiography in Primary Eye Care
OCT Angiography in Primary Eye Care An Image Interpretation Primer Julie Rodman, OD, MS, FAAO and Nadia Waheed, MD, MPH Table of Contents Diabetic Retinopathy 3-6 Choroidal Neovascularization 7-9 Central
More informationThe Human Eye. Cornea Iris. Pupil. Lens. Retina
The Retina Thin layer of light-sensitive tissue at the back of the eye (the film of the camera). Light rays are focused on the retina then transmitted to the brain. The macula is the very small area in
More informationATLAS OF OCT. Retinal Anatomy in Health & Pathology by Neal A. Adams, MD. Provided to you by:
ATLAS OF OCT Retinal Anatomy in Health & Pathology by Neal A. Adams, MD Provided to you by: Atlas of OCT The OCT Atlas is written by Neal A. Adams, MD, and produced by Heidelberg Engineering, Inc. to help
More informationIQ 532 Micropulse Green Laser treatment for Refractory Chronic Central Serous Retinopathy
Cronicon OPEN ACCESS EC OPHTHALMOLOGY Case Report IQ 532 Micropulse Green Laser treatment for Refractory Chronic Central Serous Retinopathy Fawwaz Al Mamoori* Medical Retina Department, Eye Specialty Hospital,
More informationFundus Fluorescein Angiography in Diabetic Retinopathy: Correlation of Angiographic Findings to the Clinical Maculopathy Abstract: Purpose:
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 2 Ver. XII (Feb. 2016), PP 80-88 www.iosrjournals.org Fundus Fluorescein Angiography in Diabetic
More information3/6/2014. Hoda MH Mostafa MD Associate Professor of Ophthalmology Cairo University. The author has no proprietary interest. Today s Objectives
Hoda MH Mostafa MD Associate Professor of Ophthalmology Cairo University The author has no proprietary interest Today s Objectives Identify the CLINICAL SCENARIOS IN MACULAR EDEMA where OCT plays a MAJOR
More informationA retrospective nonrandomized study was conducted at 3
Department of Ophthalmology, Kangbuk Samsung Hospital, Sungkyunkwan University College of Medicine 1, Seoul, Korea Hangil Eye Hospital 2, Incheon, Korea Seoul National University Bundang Hospital 3, Seongnam,
More informationFundus Autoflu ores cence Findings Pre and Post Intravitreal Bevacizumab Injection in Patients with Diabetic Macular Edema
Med. J. Cairo Univ., Vol. 84, No. 1, September: 1093-1100, 2016 www.medicaljournalofcairouniversity.net Fundus Autoflu ores cence Findings Pre and Post Intravitreal Bevacizumab Injection in Patients with
More informationNew Developments in the treatment of Diabetic Retinopathy
New Developments in the treatment of Diabetic Retinopathy B. Jeroen Klevering University Medical Centre Nijmegen - The Netherlands Topics Management of diabetic retinopathy Interventions a. primary (prevention)
More informationEPIRETINAL MEMBRANE & VITREOMACULAR TRACTION
EPIRETINAL MEMBRANE & VITREOMACULAR TRACTION Management of ERM and VMT K.V.Chalam,MD,PhD,MBA,FACS Professor and Director of Retina Loma Linda Eye Institute Los Angeles, USA REVIEW ANATOMY The vitreous
More informationDiabetic Retinopathy A Presentation for the Public
Diabetic Retinopathy A Presentation for the Public Ray M. Balyeat, MD The Eye Institute Tulsa, Oklahoma The Healthy Eye Light rays enter the eye through the cornea, pupil and lens. These light rays are
More informationevaluation of vitreoretinal adhesions in exudative AMD using optical coherence tomography
evaluation of vitreoretinal adhesions in exudative AMD using optical coherence tomography Dr. Mahmoud Alaa Abouhusssein, FRCO Lecturer of ophthalmology, Alexandria university Dr. Amir Ramadan Gomaa, MD
More informationFundus Autofluorescence. Jonathan A. Micieli, MD Valérie Biousse, MD
Fundus Autofluorescence Jonathan A. Micieli, MD Valérie Biousse, MD The retinal pigment epithelium (RPE) has many important functions including phagocytosis of the photoreceptor outer segments Cone Rod
More informationOCT Angiography The Next Frontier
Choroid Retina avascular 5/13/2017 OCT Angiography The Next Frontier Pierce Kenworthy OD, FAAO June 9, 2017 OCT Angiography (OCTA) 2016 Non-invasive, motion contrast imaging Represents erythrocyte movement
More informationJMSCR Vol 06 Issue 12 Page December 2018
www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i12.39 Central Macular Thickness analysis
More informationRecalcitrant Diabetic Macular Oedema: Therapeutic Options
December 2007 A. Giridhar et al. - Recalcitrant DME 451 CONSULTATION S E C T I O N Recalcitrant Diabetic Macular Oedema: Therapeutic Options Dr. Cyrus M Shroff 1, Dr. N S Muralidhar 2, Dr. R Narayanan
More informationEyes on Diabetics: How to Avoid Blindness in Diabetic Patient
Eyes on Diabetics: How to Avoid Blindness in Diabetic Patient Rova Virgana FK Unpad Pusat Mata Nasional RS Mata Cicendo Bandung Eye Center (Hospital and Clinic) PIT IDI Jabar 2018 Keys Facts from WHO
More informationScott M. Pfahler D.O. Dayton Vitreo-Retinal Associates AOCOO-HNS Palm Springs, CA 2012
Scott M. Pfahler D.O. Dayton Vitreo-Retinal Associates AOCOO-HNS Palm Springs, CA 2012 Proliferative Diabetic Retinopathy Laser Treatments Medical Treatment Surgical Treatment Diabetic Macular Edema Laser
More informationR&M Solutions
Mohamed Hosny El-Bradey, MD., Assistant Professor of Ophthalmology, Tanta University. Wael El Haig, MD., Professor of Ophthalmology. Zagazeeg University. 1 Myopic CNV is considered the most common vision
More informationDiabetic Management beyond traditional risk factors and LDL-C control: Can we improve macro and microvascular risks?
Retinopathy Diabetes has a negative effect on eyes in many ways, increasing the risk of cataracts for example, but the most common and serious ocular complication of diabetes is retinopathy. Diabetic retinopathy
More informationOPTIC DISC PIT Pathogenesis and Management OPTIC DISC PIT
OPTIC DISC PIT Pathogenesis and Management Abdel-Latif Siam Ain Shams University Cairo Egypt OPTIC DISC PIT Congenital pit is an atypical coloboma usually located on the temporal edge of the disc, associated
More informationDiabetic and the Eye: An Introduction
Diabetic and the Eye: An Introduction Lawrence Iu FRCSEd (Ophth), FCOphthHK, FHKAM (Ophthalmology) Department of Ophthalmology, Grantham Hospital & Queen Mary Hospital Background Diabetes mellitus (DM)
More informationEyePACS Grading System (Part 2): Detecting Presence and Severity of Background (Non-Proliferative) Diabetic Retinopathy Lesion
EyePACS Grading System (Part 2): Detecting Presence and Severity of Background (Non-Proliferative) Diabetic Retinopathy Lesion George Bresnick MD MPA Jorge Cuadros OD PhD Anatomy of the eye: 3 Normal Retina
More informationGanglion cell analysis by optical coherence tomography (OCT) Jonathan A. Micieli, MD Valérie Biousse, MD
Ganglion cell analysis by optical coherence tomography (OCT) Jonathan A. Micieli, MD Valérie Biousse, MD Figure 1. Normal OCT of the macula (cross section through the line indicated on the fundus photo)
More informationRole of OCT in the diagnosis and follow up of diabetic macular edema
Seminars in Ophthalmology 0882-0538/02/1701-019$16.00 2002, Vol. 17, No. 1, pp. Swets & Zeitlinger Role of OCT in the diagnosis and follow up of diabetic macular edema Giacomo Panozzo, Elena Gusson, arbara
More informationTHE EYE: RETINA AND GLOBE
Neuroanatomy Suzanne Stensaas February 24, 2011, 10:00-12:00 p.m. Reading: Waxman Ch. 15. Your histology and gross anatomy books should be useful. Reading: Histology of the Eye from any histology book
More informationINTRODUCTION. Trans Am Ophthalmol Soc 2010;108:62-76
INTERPRETING THICKNESS CHANGES IN THE DIABETIC MACULA: THE PROBLEM OF SHORT- TERM VARIATION IN OPTICAL COHERENCE TOMOGRAPHY MEASURED MACULAR THICKENING (AN AMERICAN OPHTHALMOLOGICAL SOCIETY THESIS) BY
More informationEpidemiology and Pathophysiology of Diabetic Retinopathy
Epidemiology and Pathophysiology of Diabetic Retinopathy Vincent Reppucci, MD Director, Retina Service Mt. Sinai St. Luke s-roosevelt Hospital Attending Physician, Retina Service New York Eye and Ear Infirmary
More informationCase Report Inherent Challenges in Managing Long Standing Refractory Diabetic Macular Edema
Cronicon OPEN ACCESS EC OPHTHALMOLOGY Case Report Inherent Challenges in Managing Long Standing Refractory Diabetic Macular Edema V Swetha E Jeganathan 1,2 * and Karen Madill 3 1 Department of Ophthalmology,
More informationAndrew J. Barkmeier, MD; Benjamin P. Nicholson, MA; Levent Akduman, MD
c l i n i c a l s c i e n c e Effectiveness of Laser Photocoagulation in Clinically Significant Macular Edema With Focal Versus Diffuse Parafoveal Thickening on Optical Coherence Tomography Andrew J. Barkmeier,
More informationMulti-Modal Longitudinal Evaluation of Subthreshold Laser Lesions in Human Retina, Including Scanning Laser Ophthalmoscope-Adaptive Optics Imaging
EXPERIMENTAL SCIENCE Multi-Modal Longitudinal Evaluation of Subthreshold Laser Lesions in Human Retina, Including Scanning Laser Ophthalmoscope-Adaptive Optics Imaging Edward H. Wood, MD; Theodore Leng,
More informationOptical Coherence Tomography: Pearls for the Anterior Segment Surgeon Basic Science Michael Stewart, M.D.
Optical Coherence Tomography: Pearls for the Anterior Segment Surgeon Basic Science Michael Stewart, M.D. Disclosure OCT Optical Coherence Tomography No relevant financial relationships I will refer to
More informationJi Soo Shin, Young Hoon Lee. Department of Ophthalmology, Konyang University College of Medicine, Daejeon, Korea
pissn: 1011-8942 eissn: 2092-9382 Korean J Ophthalmol 2017;31(6):497-507 https://doi.org/10.3341/kjo.2016.0108 Original Article Changes in Macular Retinal Layers and Peripapillary Nerve Fiber Layer Thickness
More informationmeasure of your overall performance. An isolated glucose test is helpful to let you know what your sugar level is at one moment, but it doesn t tell you whether or not your diabetes is under adequate control
More informationDiabetic maculopathy 11/ An update on. Miss Vasuki Sivagnanavel
Miss Vasuki Sivagnanavel Consultant Ophthalmologist An update on Diabetic maculopathy Despite advances in the management of diabetes, diabetic retinopathy is already the commonest cause of blindness among
More informationGuidelines for the Management of Diabetic Retinopathy for the Internist
Visual Disorder Guidelines for the Management of Diabetic Retinopathy for the Internist JMAJ 45(1): 1 7, 2002 Sadao HORI Professor, Department of Ophthalmology, Tokyo Women s Medical University Abstract:
More informationOptical Coherence Tomograpic Features in Idiopathic Retinitis, Vasculitis, Aneurysms and Neuroretinitis (IRVAN)
Columbia International Publishing Journal of Ophthalmic Research (2014) Research Article Optical Coherence Tomograpic Features in Idiopathic Retinitis, Vasculitis, Aneurysms and Neuroretinitis (IRVAN)
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article A Multivariate Analysis of Intravitreal Injection of Anti-VEGF Bevacizumab in the Treatment
More information8/6/17. Disclosures Aerie Pharmaceuticals Alcon BioTissue Diopsys Optovue Shire
Nathan Lighthizer, O.D., F.A.A.O. Associate Professor Assistant Dean for Clinical Care Director of Continuing Education Chief of Specialty Care Clinics Oklahoma College of Optometry Tahlequah, OK lighthiz@nsuok.edu
More informationMeasuring of the fovea and foveola using line scans and 3D Macular scans obtained with spectral domain optical coherent tomography.
Measuring of the fovea and foveola using line scans and 3D Macular scans obtained with spectral domain optical coherent tomography. Vakhrameeva O.A. 1, Moiseenko G.A. 1, Maltsev D.S. 2, Sukhinin M.V. 2,
More informationLeo Semes, OD, FAAO UAB Optometry
Leo Semes, OD, FAAO UAB Optometry Safe; inert Has long track record - over 45 years Mixes with plasma and highlights blood vessel compromise Using specific exciting (490 nm)and absorption (510 nm) filters
More informationThe College of Optometrists - Learning outcomes for the Professional Certificate in Medical Retina
Learning outcomes for the Professional Certificate in Medical Retina, incorporating diabetic retinopathy screening and age related macular degeneration The professional certificate is a prerequisite to
More informationCase report 12/10/2014. Delphine Lam ; Dr Mayer Srour Service d ophtalmologie Professeur E.Souied Université Paris Est
Case report 12/10/2014 Delphine Lam ; Dr Mayer Srour Service d ophtalmologie Professeur E.Souied Medical history Man, 75 years old Complaint: Vision loss in left eye in June 2014 Past ophthalmologic history:
More informationThe Natural History of Diabetic Retinopathy and How Primary Care Makes A Difference
The Natural History of Diabetic Retinopathy and How Primary Care Makes A Difference We will discuss - How exactly does blood sugar control affect retinopathy? - What are other factors that we measure in
More informationClinical Case Presentation. Branch Retinal Vein Occlusion. Sarita M. Registered Nurse Whangarei Base Hospital
Clinical Case Presentation on Branch Retinal Vein Occlusion Sarita M. Registered Nurse Whangarei Base Hospital Introduction Case Study Pathogenesis Clinical Features Investigations Treatment Follow-up
More informationMichael P. Blair, MD Retina Consultants, Ltd Libertyville/Des Plaines, Illinois Clinical Associate University of Chicago 17 October 2015
Michael P. Blair, MD Retina Consultants, Ltd Libertyville/Des Plaines, Illinois Clinical Associate University of Chicago 17 October 2015 So What Parts of the Eye Retina are Affected by VHL Neural tissue
More informationPhotocoagulation of disciform macular lesions
British Journal of Ophthalmology, 1979, 63, 669-673 Photocoagulation of disciform macular lesions with krypton laser A. C. BIRD AND R. H. B. GREY From the Institute of Ophthalmology, Moorfields Eye Hospital,
More informationTreatment of Diabetic Macular Edema without Intravitreal injections
Treatment of Diabetic Macular Edema without Intravitreal injections 1. Treatment of macular edema with laser only This 60 year old female presented on 02-01-2007 for retinal evaluation. She had proliferative
More informationPERIMETRIC LONG-TERM FOLLOW-UP OF DIABETIC CYSTOID MACULAR EDEMA AFTER LASER TREATMENT EXTENDED TO THE FOVEAL AVASCULAR ZONE
Perimetric long-term follow-up of diabetic cystoid macular edema 477 PERIMETRIC LONG-TERM FOLLOW-UP OF DIABETIC CYSTOID MACULAR EDEMA AFTER LASER TREATMENT EXTENDED TO THE FOVEAL AVASCULAR ZONE FRANCESCO
More informationINTRODUCTION AND SYMPTOMS
CHAPTER 1 INTRODUCTION AND SYMPTOMS Introduction of Diabetic Retinopathy Diabetic retinopathy (DR) is a potentially blinding complication of diabetes. It is defined as presence of one or more definite
More informationYasser R. Serag, MD Tamer Wasfi, MD El- Saied El-Dessoukey, MD Magdi S. Moussa, MD Anselm Kampik, MD
Microperimetric Evaluation of Brilliant Blue G- assisted Internal Limiting Membrane Peeling By Yasser R. Serag, MD Tamer Wasfi, MD El- Saied El-Dessoukey, MD Magdi S. Moussa, MD Anselm Kampik, MD The internal
More informationClinical Trials in Diabetic Retinopathy. Harry W. Flynn Jr., M.D. Nidhi Relhan Batra, M.D.
1 Clinical Trials in Diabetic Retinopathy 2018 Harry W. Flynn Jr., M.D. Nidhi Relhan Batra, M.D. Bascom Palmer Eye Institute 900 N.W. 17th Street Miami, FL 33136 Phone: (305) 326-6118 Fax: (305) 326-6417
More informationSpontaneous Large Serous Retinal Pigment Epithelial Tear
This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License (www.karger.com/oa-license), applicable to the online version of the article
More informationTissue-Sparing MicroPulse Photocoagulation
Tissue-Sparing MicroPulse Photocoagulation What is MicroPulse? A technology that finely controls thermal elevation by: chopping a CW beam into a train of repetitive microsecond pulses allowing tissue to
More informationRetinal Complications of Obstructive Sleep Apnea A Growing Concern!
Retinal Complications of Obstructive Sleep Apnea A Growing Concern! Jay M. Haynie, OD, FAAO Financial Disclosure I have received honoraria or am on the advisory board for the following companies: Carl
More informationVitreomacular interface disorders. Ghanbari MD 1393:10:25
Vitreomacular interface disorders Ghanbari MD 1393:10:25 Human vitreous after dissection of the sclera, choroid, and retina. Lamellar structure of the posterior vitreous cortex (PVC) in the monkey. V =
More informationWhat Is O.C.T. and Why Should I Give A Rip? OCT & Me How Optical Coherence Tomography Changed the Life of a Small Town Optometrist 5/19/2014
OCT & Me How Optical Coherence Tomography Changed the Life of a Small Town Optometrist Email: myoder@wcoil.com Mark A. Yoder, O.D. 107 N. Main Street PO Box 123 Bluffton, OH 45817 @yoderod 115.02 Histoplasma
More informationMedical Retina 2011 Nicholas Lee
Medical Retina 2011 Nicholas Lee 1 Diabetic Retinopathy Epidemiology 1000 registered blind each year 2% diabetics registered as blind (8% of all Blind Registrations) 42% with Mild Background DR will progress
More informationHistology of the Eye
Histology of the Eye Objectives By the end of this lecture, the student should be able to describe: The general structure of the eye. The microscopic structure of:»cornea.»retina. EYE BULB Three coats
More informationDOME SHAPED MACULOPATHY. Ιωάννης Ν. Βαγγελόπουλος Χειρ. Οφθαλμίατρος - Βόλος
DOME SHAPED MACULOPATHY Ιωάννης Ν. Βαγγελόπουλος Χειρ. Οφθαλμίατρος - Βόλος DOME SHAPED MACULOPATHY-DEFINITIONS The entity Dome Shaped Macula ( DSM ) was first described by Gaucher and associates in 2008
More informationSoluble Lutein (Lutemax2020 ) Prevents Retinal Damage in Streptozotocin (STZ)- induced Diabetic Rats
Soluble Lutein (Lutemax2020 ) Prevents Retinal Damage in Streptozotocin (STZ)- induced Diabetic Rats Vijaya Juturu, Ph.D., F.A.C.N. OmniActive Health Technologies, Inc. Morristown, NJ Acknowledgements
More informationVitreous! Retinal pigment epithelium! and the visual cycle! Retinal degenerations and pigment epithelium!
Vitreous Bruch s membrane Retinal pigment epithelium and the visual cycle Retinal degenerations and pigment epithelium Basic Science course 2017 Swiss Eye Week, Neuchâtel Ch. E. Remé, Zürich Ch.E. Remé
More informationSeokhyun Bae, Kiwon Jin, Hakyoung Kim and So Hyun Bae *
Bae et al. BMC Ophthalmology (2015) 15:180 DOI 10.1186/s12886-015-0170-4 RESEARCH ARTICLE Open Access Clinical parameters related to metamorphopsia outcome in patients with resolved central serous chorioretinopathy
More informationCitation BioMed Research International, 2015, v. 2015, article no Creative Commons: Attribution 3.0 Hong Kong License
Title Relationship between Outer Retinal Layers Thickness and Visual Acuity in Diabetic Macular Edema Author(s) Wong, RLM; Lee, JWY; Yau, GSK; Wong, IYH Citation BioMed Research International, 2015, v.
More informationCourse # Getting to Know Your OCT
Course # 140 Getting to Know Your OCT Course Title: Lecturer: Getting to Know Your OCT Brad Sutton, OD, FAAO IU School of Optometry Financial Disclosures No financial disclosures Optical Coherence Tomography-OCT
More informationMild NPDR. Moderate NPDR. Severe NPDR
Diabetic retinopathy Diabetic retinopathy is the most common cause of blindness in adults aged 35-65 years-old. Hyperglycaemia is thought to cause increased retinal blood flow and abnormal metabolism in
More informationUse of Scanning Laser Ophthalmoscope Microperimetry in Clinically Significant Macular Edema in Type 2 Diabetes Mellitus
Use of Scanning Laser Ophthalmoscope Microperimetry in Clinically Significant Macular Edema in Type 2 Diabetes Mellitus Fumihiko Mori, Satoshi Ishiko, Norihiko Kitaya, Taiichi Hikichi, Eiichi Sato, Akira
More informationJay M. Haynie, O.D.; F.A.A.O. Olympia Tacoma Renton Kennewick Washington
Jay M. Haynie, O.D.; F.A.A.O. Olympia Tacoma Renton Kennewick Washington I Jay M. Haynie, OD, FAAO have received honoraria from the following companies: Reichert Technologies Notal Vision Carl Zeiss Meditec
More informationOCT Image Analysis System for Grading and Diagnosis of Retinal Diseases and its Integration in i-hospital
Progress Report for1 st Quarter, May-July 2017 OCT Image Analysis System for Grading and Diagnosis of Retinal Diseases and its Integration in i-hospital Milestone 1: Designing Annotation tool extraction
More informationDiabesity A Public Health Crisis: AOA Evidence Based Translation to Care Series
Diabesity A Public Health Crisis: AOA Evidence Based Translation to Care Series Joseph J. Pizzimenti, OD, FAAO Associate Professor Nova Southeastern University The Eye Care Institute pizzimen@nova.edu
More informationMANAGING DIABETIC RETINOPATHY. <Your Hospital Name> <Your Logo>
MANAGING DIABETIC RETINOPATHY It s difficult living with Diabetes Mellitus. Ask any diabetic... Their lives are centered around meal plans, glucose levels, and insulin
More informationThe Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care
The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care Medical Retina November 2016 Association of Health Professions in Ophthalmology General basic
More informationMarcus Gonzales, OD, FAAO Cedar Springs Eye Clinic
Marcus Gonzales, OD, FAAO Cedar Springs Eye Clinic 25.6 million adults 11.3% of the adult population 10.9 million adults 65 years and older 26.9% of this age population 79 million people are Pre-diabetic!!
More informationThe Diabetic Retinopathy Clinical Research Network. Management of DME in Eyes with PDR
The Diabetic Retinopathy Clinical Research Network Management of DME in Eyes with PDR 1 What Has Been Learned? Diabetic Retinopathy Treatment Protocol F: Results suggest that clinically meaningful differences
More informationOptical coherence tomography in diabetic macular edema: patterns and related risk factors
Original article Optical coherence tomography in diabetic macular edema: patterns and related risk factors Mohammadreza Ahmadpour-Baghdadabad Masoudreza Manaviat Ahmad Shojaoddiny-Ardekani Yazd Diabetes
More informationCHAPTER 8 EVALUATION OF FUNDUS IMAGE ANALYSIS SYSTEM
CHAPTER 8 EVALUATION OF FUNDUS IMAGE ANALYSIS SYSTEM Diabetic retinopathy is very common retinal disease associated with diabetes. Efforts to prevent diabetic retinopathy though have yielded some results;
More informationEFFICACY OF INTRAVITREAL TRIAMCINOLONE ACETONIDE FOR THE TREATMENT OF DIABETIC MACULAR EDEMA
Basrah Journal Of Surgery EFFICACY OF INTRAVITREAL TRIAMCINOLONE ACETONIDE FOR THE TREATMENT OF DIABETIC MACULAR EDEMA Salah Zuhair Abed Al-Asadi MB,ChB, FICMS, Lecturer, Department of Surgery, College
More informationParadigm Shift in the treatment of Diabetic Retinopathy. Haytham I. S. Salti, MD Associate Professor
Paradigm Shift in the treatment of Diabetic Retinopathy Haytham I. S. Salti, MD Associate Professor Disclosure No financial interests related to the subject matter of this talk This presentation includes
More informationbiomicroscopy and stereoscopic photography are subjective and insensitive to small changes in retinal thickness ] 5[ Measurement of the integrity of t
Assessment of the Morphology of Diabetic Macular Edema Using Optical Coherence Tomography ; Ophthalmologist,DO Al Hindia general hospital/kerbala,iraq Abstract B ackground: Diabetic macular edema(dme)
More informationHistory/principles of the OCT What does the normal retinal OCT look like Vitreal disorders Retinal/RPE disorders Choroidal disorders
Nathan Lighthizer, O.D., F.A.A.O. Assistant Professor Assistant Dean for Clinical Care Director of Continuing Education Chief of Specialty Care Clinics Chief of Electrodiagnostics Clinic Oklahoma College
More informationOptical Coherence Tomography (OCT) in Uveitis Piergiorgio Neri, BMedSc, MD, PhD Head Ocular Immunology Unit
The Eye Clinic Polytechnic University of Marche Head: Prof Alfonso Giovannini November, 1991 Optical Coherence Tomography (OCT) in Uveitis Piergiorgio Neri, BMedSc, MD, PhD Head Ocular Immunology Unit
More information